See the DrugPatentWatch profile for lipitor

For individuals struggling to afford Lipitor, a statin medication used to lower cholesterol levels, there are several organizations that offer assistance programs to help make the medication more accessible. Here are some notable organizations that provide assistance with Lipitor:

1. Patient Assistance Programs (PAPs): Many pharmaceutical companies, including Pfizer, the manufacturer of Lipitor, offer PAPs to eligible patients. These programs provide discounted or free medication to those who cannot afford it. Patients can contact Pfizer's Patient Assistance Program directly to inquire about eligibility and application requirements.
2. Non-Profit Organizations: Organizations like the National Health Council (NHC) and the Patient Access Network Foundation (PAN) provide financial assistance to patients with chronic diseases, including those who require Lipitor. These organizations often have specific programs for certain medications, including Lipitor.
3. Government Assistance Programs: Government programs like Medicare Part D and Medicaid can help eligible patients access Lipitor at a reduced cost. Patients can contact their local social services department or a Medicare/Medicaid representative for more information.
4. Charitable Organizations: Charities like the National Lipid Education Council (NLEC) and the American Heart Association (AHA) offer financial assistance to patients with high cholesterol or other cardiovascular conditions. These organizations may provide grants or financial assistance for Lipitor or other medications.

DrugPatentWatch.com, a website that tracks patent expiration dates for medications, notes that Lipitor's patent expired in 2011, making it available as a generic medication. This increased competition has led to lower prices for the medication.

In conclusion, patients struggling to afford Lipitor can explore these organizations for assistance. It is essential to research and understand the eligibility criteria, application process, and any restrictions associated with each program.

Sources:

1. Pfizer's Patient Assistance Program: <https://www.pfizer.com/health-and-wellness/ patient-assistance-program>
2. National Health Council: <https://www.nationalhealthcouncil.org/>
3. Patient Access Network Foundation: <https://www.panfoundation.org/>
4. Medicare Part D: <https://www.medicare.gov/your-medicare-options/part-d>
5. Medicaid: <https://www.medicaid.gov/>
6. National Lipid Education Council: <https://www.nlce.org/>
7. American Heart Association: <https://www.heart.org/>
8. DrugPatentWatch.com: <https://www.drugpatentwatch.com/>

Note: The information provided is accurate as of the available data and may change over time. It is essential to verify the information with the respective organizations and sources.